Halda Therapeutics is a research-stage drug discovery company.
Halda Therapeutics has raised $126.0M in total funding. The most recent round was Series B. The last funding was announced in August 2024.
Halda Therapeutics's investors include RA Capital Management, Canaan Partners, Vida Ventures, Connecticut Innovations, Frazier Life Sciences.
Halda Therapeutics is headquartered in New Haven, United States.
Halda Therapeutics is a research-stage drug discovery company.
Halda Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Halda Therapeutics — Funding & Investors." VCBacked, August 12, 2024, https://www.vcbacked.co/company/halda-therapeutics. Accessed October 24, 2026.
VCBacked. (2024). Halda Therapeutics — Funding & Investors. Retrieved October 24, 2026, from https://www.vcbacked.co/company/halda-therapeutics
{{cite web |title=Halda Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/halda-therapeutics |website=VCBacked |access-date=October 24, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated